Enhertu 100 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26F9KC1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,115
Award facts
- Contract value 100% obligated
- $23,114.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $23,114.88 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 7, 2026, for the supply of Enhertu 100 mg vials. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under full and open competition. The contract completion date is scheduled for January 29, 2026, and performance will take place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal government agencies, particularly the Department of Defense healthcare systems.
This delivery order is executed under Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. The IDC encompasses a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. Enhertu, a prescription oncology medication, represents a specialized pharmaceutical commodity critical to military treatment facilities and veterans' healthcare programs supported through the DLA's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F9KC1?
SPE2DR26F9KC1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F9KC1 worth?
The government has obligated $23,115 on SPE2DR26F9KC1.
Is contract SPE2DR26F9KC1 an order under another contract?
Yes. SPE2DR26F9KC1 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9KC1 competed?
The extent of competition for SPE2DR26F9KC1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award